loader

Phone: +86-791-87793865

Shopping Cart ( 0 )

Your Have 0 Item In Your Cart

close

购物车里没有产品

作者: info@wondermedcn.com

Online medicine purchases made with insurance

Following Shanghai and several cities in Guangdong province, the Chinese capital has begun to provide online drug purchase services through individual medical insurance accounts, covering 300 pharmacies citywide to facilitate the purchasing of medicines by members of the public.

The Beijing Municipal Medical Insurance Bureau announced on Monday that insured individuals in Beijing can use their personal medical insurance accounts on two platforms, Meituan and JD, to purchase over-the-counter drugs online.

The delivery and packaging fees will be borne by the purchaser, and the purchased drugs will be promptly delivered by the online platform after placement of the order.

Beijing resident Li Yubo was among the first to try purchasing OTC drugs through the online platform after he heard the news.

“The process is simple — just log in to the platform, select drugs marked with a ‘medical insurance’ blue label, submit the order and choose ‘Beijing medical insurance personal account payment’,” he said. “It’s so handy that I don’t need to rush out on foot to buy medicine for a fever when I feel terrible. It’s a lovely policy for single people like me.”

The 300 designated retail pharmacies cover all the districts in the city.

The medical insurance bureau said that it will explore and study the practicality of online purchases of prescription drugs to provide insured individuals with more convenient and efficient services.

It also plans to continuously increase the number of designated retail pharmacies for online purchase of OTC drugs. At the same time, it will continue to strengthen the supervision of the use of medical insurance funds by designated retail pharmacies, and monitor drug prices to ensure the safe and efficient operation of medical insurance funds.

One store of the Jinxiang pharmacy chain in Beijing said it had received 21 online orders by noon on Monday, with seven to eight orders utilizing the new policy, mainly for the purchase of cold medicines.

“This policy will have some impact on offline drug purchases, as people will reduce visits to pharmacies,” a staff member said. “However, if they are unsure about which medicine to use, they will still come to us for related inquiries. This policy may be a bit challenging for the elderly to use. I think it mainly focuses on younger people.”

Beijing resident Li Xiaoli, who also tried to purchase medicine online on Monday, said there were issues with payment, such as situations where medical insurance could not be used.

“There may be a need for improvements in the payment platform,” she said. “It’s new. It takes time to be better.”

New online retail channels for pharmaceuticals have grown rapidly in recent years.

In July 2021, the National Medical Insurance Administration issued guidance that promoted “Internet + medical services” — exploring information sharing to achieve integrated services such as prescription circulation, online payment settlement and the home delivery of medicines.

Starting June 7, seven cities in Guangdong, including Dongguan and Zhongshan, started online drug purchases with medical insurance payments. Shanghai initiated an earlier pilot program.

Multinationals secure spots at 2025 China International Import Expo

Some 26 companies signed on-site to become the first batch of exhibitors for the 2025 China International Import Expo when recruitment began on Wednesday in Nanning, Guangxi Zhuang autonomous region.

L’Oréal, Volvo Cars, HSBC and Louis Dreyfus Company, among others, have signed contracts for the exhibition for eight consecutive years.

Wu Guangyu, general manager of Dun & Bradstreet China, will participate for the fifth time.

His company is a leading global business decision data and analytics provider headquartered in the United States. He sees an increasing trend of multinational companies focusing on this expo.

“Everyone hopes to utilize this platform to showcase themselves, find customers, and then locate partners,” said Wu.

“Currently, the Chinese market has a solid drive for innovation,” he added. “We also hope to increase our investment in production and research in China and leverage the innovative capabilities of the Chinese market to serve customers globally. For multinational companies, this is certainly a significant and essential market.”

Tang Wenhong, assistant minister of commerce, noted that the 2024 China International Import Expo will be held in Shanghai from November 5th to 10th this year. Exhibitor recruitment has entered the final stage, and the contracted exhibition area will exceed 350,000 square meters.

Tang further explained that as the world’s first national-level expo with imports as its theme, the previous six China International Import Expos featured over 19,000 exhibitors and showcased more than 2,400 new products, technologies and services for the first time. The expo boasts a cumulative intended transaction value exceeding $420 billion.

The signing ceremony is part of the China International Import Expo in Guangxi, a series of events held from Wednesday to Friday. The event includes themed promotion meetings and specialized matchmaking sessions in six exhibition areas featuring technology equipment, consumer goods, automobiles, food and agricultural products, medical devices and healthcare. There will also be on-site inspection and exchange activities.

Italy shares full confidence in China’s innovative medical field

Following stable trade exchanges in the medical field between Italy and China over the past years, Italy has full confidence in continuous growth in this realm and beyond in the China market, said executives with the country’s governmental trade agency and chamber of commerce during the 2024 China Medical Equipment Fair.

There will certainly be more and deeper opportunities for cooperation between the two countries, which are celebrating the 20th anniversary of the establishment of a comprehensive strategic partnership this year, said Augusto Di Giacinto, Trade Commissioner of the Shanghai office of Italian Trade Agency, an governmental organization of the country to support and promote exports and cooperation of Italian enterprises abroad.

“The presence of 12 innovative enterprises from Italy with cutting-edge technologies in respective areas, including diagnostics, imaging, equipment for ambulances and testing, at this year’s CMEF, demonstrated our belief in the potentials of the China market,” said Di Giacinto during the fair. The fair concluded in Shanghai on Sunday.

“All the Italian exhibitors expressed how they were extremely impressed by the fair, which attracted over 5,000 companies to participate, showing the vitality of the Chinese market,” he said.

Italian medical device industry is pretty advanced, they said, with more than 4,400 enterprises in this industry. The revenue of the industry reached 15 billion euros ($16 billion) in 2023 following a stride from the previous year, and the volume of exports far exceeded that locally, according to statistics from the agency.

China is Italy’s seventh largest export destination regarding medical devices, with total exports nearing 160 million euros last year, according to the governmental figure of Italy.

Chinese doctors perform life-changing surgery on Madagascan patient

Chinese doctors from the 23rd medical team to aid Madagascar successfully removed a giant thyroid tumor from a female patient at a hospital in Sambava despite surgery difficulties.

Before coming to doctor Qiang Yaosheng’s office, the 53-year-old patient’s tumor had been growing on her neck for over 15 years, and the continuous growth had caused hoarseness of voice and difficulty in tilting her head back. The patient also had shortness of breath.

Qiang, deputy chief physician of the Department of General Surgery at the First Hospital of Lanzhou University, contacted Li Guangcheng, an otolaryngologist in Madagascar, for discussion.

They confirmed that the tumor had affected the recurrent laryngeal nerve, causing paralysis of the right vocal cord. However, due to the patient’s long-standing non-physiological neck bending, performing the surgery in the traditional supine position was impossible. The surgery would be complicated and risky.

On Aug 23, they decided to do the surgery as all her examination indicators met the requirements. However, intubation under general anesthesia was extremely difficult due to a lack of complete anesthesia equipment and the large size of the tumor.

Instead, they used cervical plexus anesthesia. They completely removed the right thyroid gland and the tumor, and the surgery proceeded smoothly without complications.

The patient, accompanied by her husband, recently visited the medical team to express her gratitude.

Patients benefiting from unified healthcare systems

The number of cross-regional hospital visits in China — a sign of uneven distribution of medical resources — has fallen significantly in recent years thanks to efforts made to ramp up overall public healthcare capacity, health officials said during a news conference on Tuesday.

Zhu Hongbiao, an official at the National Health Commission’s department of healthcare reform, said that China has so far set up 13 national medical centers specializing in different fields of medicine, 125 national-level regional medical centers and 114 provincial-level regional medical facilities.

National medical centers represent top-notch diagnosis and treatment levels in a specific medical field, while regional medical centers are tasked with providing patients in different regions with quality services closer to their homes.

Zhu added that 81 cities across the nation have launched pilot programs to unite urban hospitals under one coordinated system, and county-level authorities have pushed forward reforms to link local medical facilities together to offer consistent healthcare services for residents.

Xing Ruoqi, an official at the commission’s department of medical administration, said that local authorities have also improved hospital appointment systems, streamlined procedures for transferring patients and set up novel outpatient clinics in anesthesia, pain relief and health management to make the treatment process more convenient for patients and to meet their diversified demands.

Shanghai Zhongshan Hospital medical experts perform world’s first minimally invasive tumor resection

Medical experts at Shanghai Zhongshan Hospital recently performed the world’s first tumor resection by breaking into the pleura in an ultra-minimally invasive way with the assistance of endoscope, marking another major technological breakthrough in the field of minimally invasive resection with endoscope.

Zhou Pinghong, director of the Endoscope Center of the hospital affiliated with Fudan University, performed the surgery on March 20. He shared the case at the Shanghai Symposium of Endoscopology held in Shanghai from Friday through Sunday.

During the operation, the surgeon entered the patient’s thoracic cavity with the esophageal tunnel endoscope and used submucosaltunnel endoscopic resection, or STER technique, to precisely peel away the mass while preserving the patient’s esophageal function.

The patient, a 28-year-old woman, has recovered well and has been discharged from hospital, according to the hospital.

Diagnosed with a large mass under the esophageal mucosa, the patient once faced the grim choice of thoracotomy to remove part of her esophagus. It meant that she may need to undergo digestive tract reconstruction and was at risk of esophageal fistula and esophageal strictures, among other things.

The hospital said that the successful implementation of the surgical operation has further broken the taboo in minimally invasive surgeries.

More than 3,500 representatives from the medical field from across the country participated in the symposium offline. Altogether 50 outstanding endoscopists from around the world completed 56 demonstration surgeries during the conference, covering a wide range of segments from the lumen of the digestive tract to extraluminal lesions.

New efforts and better services good for eldercare

Our community service center released a notice on its WeChat account recently, informing those above the age of 80 to apply for an emergency call device at home. The device and installation will both be free of cost, and it’s up to the aged people to decide if they want to install one at home, the notice said.

Although still “too young” to be eligible for the free service, I welcome the move by the Beijing local authorities to ensure the elderly people receive better old-age care services. I welcome the move also because I can expect a more mature eldercare service if I need a stick or wheelchair to move around in the future.

The number of people in China aged 60 or above was 280 million — more than the total population of Indonesia, the world’s fourth most populous country. With the aging population increasing by more than 10 million every year, taking good care of the elderly is becoming a challenge for governments at all levels.

The Chinese people still take it for granted that they will spend their old age with their children and grandchildren. But now that families are becoming smaller — averaging 2.62 individuals per family in 2021 — more and more elderly people live alone. And even if people visit their elderly parents regularly, the fact that they are mostly the only child of the family makes it difficult for them to tend to all the needs of their parents, not to mention their grandparents.

In rural areas where couples usually have more than one child, the elderly are happy to live with the family of their children, who, to earn more, generally migrate to cities and towns and visit their parents only during the Spring Festival holidays — an occasion from traditional family reunion.

Shifting to old-age homes can be a choice for the aged, though one has to have a fat wallet to afford a bed or a room in an old-age home, because it could cost up to 10,000 yuan ($1,406.82) per month, far more than the average pension elderly people get. Old-age homes today have more than 8 million beds. But since about 10 percent of the elderly people, according to surveys, prefer to stay in old-age homes, the demand for beds/rooms in such homes is several times higher than supply.

Although the government has expedited the construction of old-age homes to meet the increasing demand, the officials at different levels have realized that it’s a mission impossible to provide enough beds for all the elderly people.

Studies conducted in different regions of China show that the best eldercare model is neither the traditional home-stay option nor the old-age home arrangement but rather a mixture of the two. If governance is strengthened and arrangements improved, the elderly people can stay in their familiar homes and be taken care of by eldercare professionals from local community centers and some companies that provide all the eldercare services one can think of.

My community’s offer of installing emergency call devices for those advanced in age is part of the local government’s efforts to promote the new eldercare model. The model, also called the one-button model, enables an elderly person to get the necessary support any time he/she needs. By pressing a button on the device, one can seek immediate help, from calling an ambulance to getting someone to come and trim your nails, from ordering a meal or medicines to getting someone for a massage or simply to chat.

These are paid services and a senior citizen can purchase them if he/she can afford it. Once established, it will become a major sector employing millions of people, and thus reduce the unemployment rate. In fact, many medical colleges are already enrolling more students in the eldercare service major.

Understandably, the promotion of the new business model requires big investments, huge human resources and wide publicity to make it successful. Difficult as it is, popularizing the new eldercare service model is probably the only practical option for China to address the problem of a rapidly rising aging population.

Latest therapies, medical tech have strong presence at CIIE

Many of the latest therapies and medical technologies by multinational companies are having a strong presence during the ongoing China International Import Expo (CIIE), demonstrating the enterprises’ further aspirations to help Chinese patients with unmet medical needs and access to the world’s most advanced treatment solutions.

Germany-based Drager Medical Equipment, which specializes in critical care, exhibited an anesthesia workstation with ICU-level ventilation performance. It guarantees precise tidal volume delivery, active positive end-expiratory pressure, and high-trigger sensitivity for spontaneous breathing.

This equipment Atlan designed to provide a leak-tight breathing system, sample-gas recirculation function, and a heated breathing system to reduce condensation, has been widely used during the COVID-19 pandemic in the United States and Europe and is scheduled to be launched in the China market in 2021, the company said.

The machine offers a wide range of functions to help make the anesthesia process safer for both patients and healthcare workers, the company said. For example, it is equipped with smart tools to assist making informed decisions and to help avoid incorrect connection of breathing hoses with the anesthesia device leading to the inability to ventilate the patient.

French pharmaceutical company Sanofi, which aims to become the most trusted specialty care team in China by 2025, exhibited its blockbuster products, including a new oncology product treating patients with relapsed and refractory multiple myeloma and those in the rare disease field, including a first-in-class drug treating hemophilia A and B.

As a major industry player in rare disease, the company’s two main exhibits during the previous two editions of CIIE – one to treat Fabry disease and the other for mucopolysaccharidosis Type I, or MPS I, have been launched in the country.

“Six new products in the areas of atopic dermatitis, rare diseases and chronic diseases, which used to be offerings showcased at the past two years’ CIIEs to satisfy unmet needs to Chinese patients, have already been launched in China despite the COVID-19 pandemic,” said Bill Sibold, executive vice-president and head of Sanofi Genzyme.

Medtronic, an Ireland-based medical technology company, showcased at CIIE an innovative implantable cardioverter-defibrillator (ICD) to treat tachyarrhythmia and prevent sudden cardiac death as well as a cardiac pacemaker compatible with MRI screening. Data from Beijing Fuwai Hospital in 2018 showed that 540,000 individuals suffered from sudden cardiac death in China

Medical Development

The world’s smallest wireless pacemaker, which is about the size of an antibiotic pill. Since 2001, The company has introduced more than 500 new products to China.

One of the first companies to sign up for the expo, said it values the business opportunities offered by CIIE.

It is debuting a new line of healthcare products at its 300-square-meter booth, which is divided into two sections: one for healthcare products and the other for highly functional materials.

Traditionally a photographic film maker, the company has branched out into fields such as medical imaging and optical components since it launched a transformation strategy in 2000.

“The expo is a great platform to showcase how the company has successfully transformed into a technology-driven, innovative company that operates in multiple business fields,” said Hironobu Taketomi, president. “We hope to deepen our localization development strategy through CIIE and further expand business cooperation with Chinese companies.”

Products on show include cutting-edge early diagnosis devices for female breast cancer, and a 3D medical network system that provides stereoscopic imaging for reference purposes when surgical treatment plans are being drawn up.

The company is also showcasing a device that integrates AI technology with traditional imaging techniques, allowing radiologists to make diagnoses through database comparisons.